"XBB" の関連情報検索結果

Real-World Data Highlight Effectiveness of XBB.1.5-Adapted COVID-19 Vaccines - Vaccine Advisor



Real-World Data Highlight Effectiveness of XBB.1.5-Adapted COVID-19 Vaccines  Vaccine Advisor

Immune imprinting toward SARS-CoV-2 XBB: implications for vaccine strategy and variant risk asses...



Immune imprinting toward SARS-CoV-2 XBB: implications for vaccine strategy and variant risk assessment  Nature

Types of data requested to inform December 2025 COVID-19 vaccine antigen composition deliberation...



Types of data requested to inform December 2025 COVID-19 vaccine antigen composition deliberations  World Health Organization (WHO)

How Effective are Boosters against XBB.1.5 and Other COVID Variants? - Pan-American Life Insuranc...



How Effective are Boosters against XBB.1.5 and Other COVID Variants?  Pan-American Life Insurance Group

The World's First Fixed Income ETFs Turn 25 - ETF Trends



The World's First Fixed Income ETFs Turn 25  ETF Trends

Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case s...



Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case series study  Nature

XBB.1.5 Omicron subvariant: Questions patients may have - American Medical Association



XBB.1.5 Omicron subvariant: Questions patients may have  American Medical Association

Mucosal adenovirus vaccine Ad5-XBB.1.5 boosting elicits nasal IgA and transiently prevents JN.1 w...



Mucosal adenovirus vaccine Ad5-XBB.1.5 boosting elicits nasal IgA and transiently prevents JN.1 wave infection for less than 6 months in real-world settings  EurekAlert!

Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design - Duke University School of Medicine



Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design  Duke University School of Medicine

New COVID variant NB.1.8.1 spreads across continents amid calls for vigilance - News-Medical



New COVID variant NB.1.8.1 spreads across continents amid calls for vigilance  News-Medical

What You Need to Know About XBB.1.5, the Latest Omicron Variant - Johns Hopkins Bloomberg School ...



What You Need to Know About XBB.1.5, the Latest Omicron Variant  Johns Hopkins Bloomberg School of Public Health

Durability of XBB.1.5 Vaccines against Omicron Subvariants - The New England Journal of Medicine



Durability of XBB.1.5 Vaccines against Omicron Subvariants  The New England Journal of Medicine

The bond-fund model built for a falling-rate world hasn’t aged well - The Globe and Mail



The bond-fund model built for a falling-rate world hasn’t aged well  The Globe and Mail

TAG-VE statement on Omicron sublineages BQ.1 and XBB - World Health Organization (WHO)



TAG-VE statement on Omicron sublineages BQ.1 and XBB  World Health Organization (WHO)

Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection - ...



Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection  Nature

Clinical manifestations and severity of COVID-19 caused by Omicron among paediatric patients aged...



Clinical manifestations and severity of COVID-19 caused by Omicron among paediatric patients aged 0–17 years in Italy  Nature

Humoral immunity and clinical characteristics of Chinese college students experiencing a BA.5/BF....



Humoral immunity and clinical characteristics of Chinese college students experiencing a BA.5/BF.7 and XBB.1.5 wave  Nature

Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutra...



Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutralizing antibodies  Nature

Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-1...



Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-19 vaccination  Nature

Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vacci...



Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vaccines  Nature

Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System - Nature



Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System  Nature

Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitnes...



Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitness and antibody evasion  Nature

Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicr...



Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants  Nature

Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant - Nature



Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant  Nature

XBB: Innovative Fund From BondBloxx, But Spreads Are Too Tight - Seeking Alpha



XBB: Innovative Fund From BondBloxx, But Spreads Are Too Tight  Seeking Alpha

Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1 - Nature



Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1  Nature

Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB - The New England Journal...



Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB  The New England Journal of Medicine

Arcturus: WHO upgrades XBB.1.16 to a COVID-19 “variant of interest” - Gavi, the Vaccine Alliance



Arcturus: WHO upgrades XBB.1.16 to a COVID-19 “variant of interest”  Gavi, the Vaccine Alliance

COVID-19 Vaccines Should Be Monovalent and Contain the XBB Strain, FDA Committee Recommends - Con...



COVID-19 Vaccines Should Be Monovalent and Contain the XBB Strain, FDA Committee Recommends  Contagion Live

Omicron XBB.1.5 'Kraken' Subvariant Is on the Rise: What To Know - Yale Medicine



Omicron XBB.1.5 'Kraken' Subvariant Is on the Rise: What To Know  Yale Medicine

What to know about XBB.1.5, a new and highly transmissible COVID-19 subvariant - PBS



What to know about XBB.1.5, a new and highly transmissible COVID-19 subvariant  PBS

Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity | npj Vacc...



Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity | npj Vaccines  Nature

Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 - The New Engla...



Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1  The New England Journal of Medicine

XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such a...



XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies | mBio  ASM Journals

The emergence of the Omicron XBB.1.5 variant in India: a brief report on clinical presentation of...



The emergence of the Omicron XBB.1.5 variant in India: a brief report on clinical presentation of a few cases  Frontiers

Not just Singapore: The highly immune-evasive XBB COVID variant has been identified in 26 countri...



Not just Singapore: The highly immune-evasive XBB COVID variant has been identified in 26 countries, the WHO says  Fortune

WHO weighs in on Omicron XBB.1.5 subvariant; US extends COVID health emergency - CIDRAP



WHO weighs in on Omicron XBB.1.5 subvariant; US extends COVID health emergency  CIDRAP

WHO tracking Omicron XBB.1.16 subvariant, rising cases in some countries - CIDRAP



WHO tracking Omicron XBB.1.16 subvariant, rising cases in some countries  CIDRAP

XBB.1.5: What You Need to Know About COVID-19’s ‘Kraken’ Variant - UC Davis



XBB.1.5: What You Need to Know About COVID-19’s ‘Kraken’ Variant  UC Davis

Rising cases of COVID-19 variant, XBB.1.5 - Mayo Clinic News Network



Rising cases of COVID-19 variant, XBB.1.5  Mayo Clinic News Network

Statement on the antigen composition of COVID-19 vaccines - World Health Organization (WHO)



Statement on the antigen composition of COVID-19 vaccines  World Health Organization (WHO)

Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein va...



Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a single-arm phase 2/3 study  The Lancet

COVID-19 XBB-Adapted Vaccine Less Effective Against JN.1 vs XBB Sublineages - Infectious Disease ...



COVID-19 XBB-Adapted Vaccine Less Effective Against JN.1 vs XBB Sublineages  Infectious Disease Advisor

Characteristics of the omicron XBB subvariant wave in Singapore - The Lancet



Characteristics of the omicron XBB subvariant wave in Singapore  The Lancet

A new variant alert - Ground Truths | Eric Topol



A new variant alert  Ground Truths | Eric Topol

Don’t believe warning about ‘different and deadly’ coronavirus ‘XBB variant’ – old false story ci...



Don’t believe warning about ‘different and deadly’ coronavirus ‘XBB variant’ – old false story circulating again  Africa Check

Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 s...



Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 subvariants: preclinical and phase 1 clinical trials  Nature

FDA panel backs monovalent XBB switch for fall COVID vaccines - CIDRAP



FDA panel backs monovalent XBB switch for fall COVID vaccines  CIDRAP

Kids may be more likely to get the new ‘Cicada’ variant of Covid-19, scientists say. Here’s what ...



Kids may be more likely to get the new ‘Cicada’ variant of Covid-19, scientists say. Here’s what to know about BA.3.2  CNN

XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses...



XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses against EG.5.1 and emerging XBB variants | Scientific Reports  Nature

The ‘Kraken’ subvariant XBB.1.5 sounds scary. But behind the headlines are clues to where COVID’s...



The ‘Kraken’ subvariant XBB.1.5 sounds scary. But behind the headlines are clues to where COVID’s heading  The Conversation

Robust neutralizing antibody response to the XBB.1.5 trivalent recombinant protein vaccine booste...



Robust neutralizing antibody response to the XBB.1.5 trivalent recombinant protein vaccine booster  Nature

WHO issues initial Omicron XBB.1.16 risk assessment - CIDRAP



WHO issues initial Omicron XBB.1.16 risk assessment  CIDRAP

Could the “Arcturus” variant trigger a new wave of COVID-19 infections and deaths? - Gavi, the Va...



Could the “Arcturus” variant trigger a new wave of COVID-19 infections and deaths?  Gavi, the Vaccine Alliance

Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines - The New England Journal of Medi...



Neutralization of BQ.1, BQ.1.1, and XBB with RBD-Dimer Vaccines  The New England Journal of Medicine

Genomic surveillance and vaccine response to the dominant SARS-CoV-2 XBB lineage in Rio Grande do...



Genomic surveillance and vaccine response to the dominant SARS-CoV-2 XBB lineage in Rio Grande do Sul  Nature

Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant - Nature



Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant  Nature

WHO advisers recommend switch to monovalent XBB COVID vaccine - CIDRAP



WHO advisers recommend switch to monovalent XBB COVID vaccine  CIDRAP

XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such a...



XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies  ASM Journals

Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination - The Lancet



Humoral and cellular immune responses following BNT162b2 XBB.1.5 vaccination  The Lancet

What we know about XBB.1.5, the dominant COVID variant in the US - NewsNation



What we know about XBB.1.5, the dominant COVID variant in the US  NewsNation

Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles ...



Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles weekly  CNBC

CDC: Updated COVID-19 booster helps protect against omicron XBB variants | AHA News - American Ho...



CDC: Updated COVID-19 booster helps protect against omicron XBB variants | AHA News  American Hospital Association

Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhum...



Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates  Nature

XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids - CIDRAP



XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids  CIDRAP

Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors ...



Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors after allogeneic hematopoietic stem cell transplantation | Scientific Reports  Nature

What we know about the XBB.1.5 COVID variant sweeping the Northeast - The Hill



What we know about the XBB.1.5 COVID variant sweeping the Northeast  The Hill

Altered receptor binding, antibody evasion and retention of T cell recognition by the SARS-CoV-2 ...



Altered receptor binding, antibody evasion and retention of T cell recognition by the SARS-CoV-2 XBB.1.5 spike protein  Nature

FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall - CNBC



FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall  CNBC

BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 varian...



BA.5 bivalent booster vaccination enhances neutralization of XBB.1.5, XBB.1.16 and XBB.1.9 variants in patients with lung cancer  Nature

XBB.1.16 picks up speed in US as WHO experts weigh COVID vaccine composition - CIDRAP



XBB.1.16 picks up speed in US as WHO experts weigh COVID vaccine composition  CIDRAP

Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 ...



Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 omicron variant in Bangkok, Thailand: December 2022–August 2023  Nature

How Worried Should We Be About XBB.1.5? - The Atlantic



How Worried Should We Be About XBB.1.5?  The Atlantic

Reported levels of global COVID-19 decrease as XBB.1.5 seen across Europe, US - CIDRAP



Reported levels of global COVID-19 decrease as XBB.1.5 seen across Europe, US  CIDRAP

How the latest Covid-19 variant is shaping the course of the pandemic - vox.com



How the latest Covid-19 variant is shaping the course of the pandemic  vox.com

The Updated COVID-19 Shot Works on the Newest Variants - Time Magazine



The Updated COVID-19 Shot Works on the Newest Variants  Time Magazine

XBB booster offers protection against JN.1 infections, hospital cases, new data show - CIDRAP



XBB booster offers protection against JN.1 infections, hospital cases, new data show  CIDRAP

XBB Subvariant Now 83% of All COVID Cases in New England. But Don't Be Alarmed - NBC Boston



XBB Subvariant Now 83% of All COVID Cases in New England. But Don't Be Alarmed  NBC Boston

Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden - The ...



Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden  The Lancet

XBB.1.5 Omicron subvariant now dominant in all US regions - CIDRAP



XBB.1.5 Omicron subvariant now dominant in all US regions  CIDRAP

The ‘kraken’ COVID variant XBB.1.5 is rising quickly in the US – here’s what it could mean for th...



The ‘kraken’ COVID variant XBB.1.5 is rising quickly in the US – here’s what it could mean for the UK  The Conversation

‘Nightmare' XBB Variant Likely Already Here, Boston Doctors Say - NBC Boston



‘Nightmare' XBB Variant Likely Already Here, Boston Doctors Say  NBC Boston

COVID variant XBB.1.5 may be poised to sweep Michigan: What to know - BridgeDetroit



COVID variant XBB.1.5 may be poised to sweep Michigan: What to know  BridgeDetroit

WHO advisers weigh in on Omicron XBB and BQ.1 subvariants - CIDRAP



WHO advisers weigh in on Omicron XBB and BQ.1 subvariants  CIDRAP

Omicron XBB.1.5 variant expands US dominance - CIDRAP



Omicron XBB.1.5 variant expands US dominance  CIDRAP

Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA...



Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA.4/5, and XBB dominance in Hong Kong: a prospective cohort study  The Lancet

Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-va...



Neutralization against Omicron sublineages (BA.2/BA.5/BQ.1.1/XBB/XBB.1.5) in bivalent BNT162b2-vaccinated HCWs with or without risk factors, or following BT infection with Omicron  Nature

Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infecti...



Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infection or vaccination in children  Nature

US COVID markers continue upward trend as newer XBB variant proportions grow - CIDRAP



US COVID markers continue upward trend as newer XBB variant proportions grow  CIDRAP

Why COVID’s XBB.1.5 ‘Kraken’ Variant Is So Contagious - Scientific American



Why COVID’s XBB.1.5 ‘Kraken’ Variant Is So Contagious  Scientific American

WHO advisers recommend sticking with monovalent COVID XBB.1.5 vaccines - CIDRAP



WHO advisers recommend sticking with monovalent COVID XBB.1.5 vaccines  CIDRAP

How much should people worry about Covid’s XBB.1.5 variant? Our medical analyst explains - CNN



How much should people worry about Covid’s XBB.1.5 variant? Our medical analyst explains  CNN

Mayo Clinic expert talks about the new omicron variant - Mayo Clinic News Network



Mayo Clinic expert talks about the new omicron variant  Mayo Clinic News Network

Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters | Communications Biol...



Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters | Communications Biology  Nature

Do Coloradans need to care about the new COVID variant XBB? Yeah, probably. - The Colorado Sun



Do Coloradans need to care about the new COVID variant XBB? Yeah, probably.  The Colorado Sun

Neutralization against XBB.1 and XBB.1.5 after omicron subvariants breakthrough infection or rein...



Neutralization against XBB.1 and XBB.1.5 after omicron subvariants breakthrough infection or reinfection  The Lancet

From Centaurus to XBB: your handy guide to the latest COVID subvariants (and why some are more wo...



From Centaurus to XBB: your handy guide to the latest COVID subvariants (and why some are more worrying than others)  The Conversation

How COVID Subvariant XBB.1.5 Got Called ‘the Kraken' — and Is That Fearmongering? - NBC Boston



How COVID Subvariant XBB.1.5 Got Called ‘the Kraken' — and Is That Fearmongering?  NBC Boston

Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection - Nature



Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection  Nature

A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB.1.16,...



A bispecific antibody exhibits broad neutralization against SARS-CoV-2 Omicron variants XBB.1.16, BQ.1.1 and sarbecoviruses  Nature